Average annual compensation for US plastic surgeons reached $625,757 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in the specialty. US plastic surgeons recorded average annual compensation of $625,757, according to Doximity’s 2026 Physician Compensation Report. The latest figure provides plastic surgeons with a specialty-specific benchmark when evaluating their compensation, employment opportunities and the financial expectations associated with their practice. Key findings Doximity reports average annual compensation of $625,757 for plastic surgeons in its 2026 Physician Compensation Report. For plastic surgeons, the figure provides a useful national reference point across a specialty that encompasses reconstructive and aesthetic procedures and can involve substantially different clinical and practice models. The national average should not be interpreted as the compensation every plastic surgeon will receive. Individual earnings can vary considerably according to geography, experience, subspecialty focus, procedure mix, practice setting and employment structure. Plastic surgeon compensation reaches $625,757 The $625,757 average establishes a current national compensation benchmark for US plastic surgeons. Plastic surgery encompasses a broad range of procedures, including reconstructive surgery following trauma, cancer or congenital conditions, as well as aesthetic surgery. Individual surgeons may also specialise in areas such as hand surgery, microsurgery, craniofacial surgery or breast reconstruction. As a result, the clinical and financial profile of one plastic surgery practice can differ considerably from another. For plastic surgeons reviewing their current compensation or considering a new opportunity, the Doximity figure provides a useful specialty-specific reference against which an individual compensation package can be assessed. What influences plastic surgeon compensation? Plastic surgery is a highly procedural specialty, meaning procedure volume, case mix and subspecialty focus can all be important when evaluating individual compensation. Practice model is particularly relevant. Plastic surgeons may work within hospitals, health systems, academic medical centres, specialist groups or independent practices, and the way physicians are compensated can vary substantially between these settings. The balance between reconstructive and aesthetic work can also affect the financial structure of a practice. Reconstructive procedures may be reimbursed through insurers or healthcare systems, while some aesthetic procedures can operate through different payment arrangements. Geography, experience, referral patterns, surgical workload and additional leadership or academic responsibilities may further influence individual compensation. These factors mean the $625,757 national average should be treated as a benchmark rather than an expected salary for every plastic surgeon. What the latest figure means for plastic surgeons For US plastic surgeons, $625,757 provides a contemporary national reference point when benchmarking current compensation or evaluating a prospective position. When reviewing an opportunity, plastic surgeons should consider the headline compensation alongside procedure mix, expected surgical volume, working hours, call commitments, productivity requirements and the structure of the practice. The distinction between different plastic surgery practice models is also important. Two surgeons working within the same specialty may have very different revenue and compensation structures depending on their balance of reconstructive and aesthetic work and whether they are employed or operate within an independent practice. The latest Doximity figure therefore provides plastic surgeons with a useful starting point for evaluating compensation while recognising that individual earnings can differ significantly according to the nature and structure of their practice. About the data The Doximity 2026 Physician Compensation Report provides compensation benchmarks across a wide range of US medical and surgical specialties. The specialty figures represent average compensation and should be treated as national benchmarks. An individual plastic surgeon’s compensation may differ according to geography, experience, procedural activity, subspecialty, practice setting and other professional factors. Source Doximity. Physician Compensation Report 2026.https://www.doximity.com/reports/physician-compensation-report/2026#modal-close Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Average annual compensation for US colon and rectal surgeons reached $492,802 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in the specialty. US colon and rectal surgeons recorded average annual compensation of $492,802, according to Doximity’s 2026 Physician Compensation Report. The latest figure provides colorectal surgeons with a specialty-specific benchmark when evaluating their compensation, employment opportunities and the financial expectations associated with their practice. Key findings Doximity reports average annual compensation of $492,802 for Colon & Rectal Surgery in its 2026 Physician Compensation Report. For colon and rectal surgeons, the figure provides a useful national reference point within a specialty combining the diagnosis and management of colorectal disease with significant operative and procedural activity. The national average should not be interpreted as the compensation every colorectal surgeon will receive. Individual earnings can vary according to geography, experience, surgical volume, case complexity, subspecialty focus, call responsibilities, practice setting and employment structure. Colon and rectal surgeon compensation reaches $492,802 The $492,802 average establishes a current national compensation benchmark for US colon and rectal surgeons. Colorectal surgery encompasses the surgical management of diseases affecting the colon, rectum and anus. Clinical practice can include the treatment of colorectal cancer, inflammatory bowel disease, diverticular disease and other benign and malignant colorectal conditions. Depending on their practice, surgeons may perform open, laparoscopic and robotic procedures alongside diagnostic and therapeutic interventions and long-term postoperative care. The balance between cancer surgery, inflammatory bowel disease, benign colorectal conditions and other areas of practice can therefore create substantially different clinical workloads between individual surgeons. For colorectal surgeons reviewing their current compensation or considering a new position, the Doximity figure provides a useful specialty-specific reference against which an individual package can be assessed. What influences colon and rectal surgeon compensation? Colon and rectal surgery is a highly procedural specialty, meaning surgical volume, case complexity, procedure mix and patient workload can all be important when evaluating individual compensation. A colorectal surgeon managing complex colorectal cancer or inflammatory bowel disease may have different operative and multidisciplinary responsibilities from a physician whose practice includes a greater proportion of benign colorectal disease and outpatient procedures. Call responsibilities can also affect the demands of individual positions, particularly where surgeons provide emergency coverage for acute colorectal conditions. Geography, experience and employment structure may further influence compensation. Colorectal surgeons can work within hospitals, health systems, academic medical centres, cancer centres and specialist surgical groups, with different organisations using different salary, productivity and incentive arrangements. These factors mean the $492,802 national average should be treated as a benchmark rather than an expected salary for every colon and rectal surgeon. What the latest figure means for colon and rectal surgeons For US colon and rectal surgeons, $492,802 provides a contemporary national reference point when benchmarking existing compensation or assessing a prospective position. When reviewing an employment opportunity, colorectal surgeons should consider headline compensation alongside expected surgical volumes, case complexity, operating time, call commitments, working hours and productivity requirements. The precise composition of the practice is particularly relevant. A role with a substantial colorectal oncology caseload, for example, may carry different surgical and multidisciplinary responsibilities from one focused more heavily on benign colorectal disease. The latest Doximity figure therefore provides colon and rectal surgeons with a useful starting point for evaluating compensation while recognising that individual earnings can differ substantially according to the clinical and contractual characteristics of a particular role. About the data The Doximity 2026 Physician Compensation Report provides compensation benchmarks across a wide range of US medical and surgical specialties. The specialty figures represent average compensation and should be treated as national benchmarks. An individual colon and rectal surgeon’s compensation may differ according to geography, experience, surgical volume, case complexity, call responsibilities, practice setting and other professional factors. Source Doximity. Physician Compensation Report 2026.https://www.doximity.com/reports/physician-compensation-report/2026#modal-close Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Average annual compensation for US ophthalmologists reached $487,438 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in ophthalmology. US ophthalmologists recorded average annual compensation of $487,438, according to Doximity’s 2026 Physician Compensation Report. The latest figure provides ophthalmologists with a specialty-specific benchmark when evaluating their compensation, employment opportunities and the financial expectations associated with their practice. Key findings Doximity reports average annual compensation of $487,438 for ophthalmologists in its 2026 Physician Compensation Report. For ophthalmologists, the figure provides a useful national reference point within a specialty combining the diagnosis and long-term management of eye disease with substantial diagnostic, procedural and surgical activity. The national average should not be interpreted as the compensation every ophthalmologist will receive. Individual earnings can vary according to geography, experience, patient volume, surgical workload, subspecialty focus, practice setting and employment structure. Ophthalmologist compensation reaches $487,438 The $487,438 average establishes a current national compensation benchmark for US ophthalmologists. Ophthalmology encompasses the diagnosis and treatment of a broad range of conditions affecting the eye and vision, including cataracts, glaucoma, retinal diseases, corneal disorders and other acute and chronic ophthalmic conditions. Clinical practice can combine outpatient consultations and diagnostic testing with procedures such as intravitreal injections, laser treatments and ophthalmic surgery. Individual ophthalmologists may also develop expertise in areas such as retina, glaucoma, cornea, oculoplastics, pediatric ophthalmology or neuro-ophthalmology, creating considerable variation between individual practices. For ophthalmologists reviewing their current compensation or considering a new position, the Doximity figure provides a useful specialty-specific reference against which an individual package can be assessed. What influences ophthalmologist compensation? Ophthalmology combines high-volume outpatient care with significant procedural and surgical activity, meaning patient volume, procedure mix, surgical workload and subspecialty focus can all be important when evaluating individual compensation. An ophthalmologist undertaking a substantial volume of cataract surgery may have a different clinical and financial profile from a retinal specialist managing patients requiring repeated imaging, injections and complex vitreoretinal procedures. Practice structure can also influence compensation. Ophthalmologists may work within hospitals, academic medical centres, health systems, specialist ophthalmology groups or independent practices, with different organisations using different salary, productivity and incentive arrangements. Geography, experience and additional clinical, academic or leadership responsibilities may further influence an individual ophthalmologist's compensation. These factors mean the $487,438 national average should be treated as a benchmark rather than an expected salary for every ophthalmologist. What the latest figure means for ophthalmologists For US ophthalmologists, $487,438 provides a contemporary national reference point when benchmarking existing compensation or assessing a prospective position. When reviewing an employment opportunity, ophthalmologists should consider headline compensation alongside expected patient volumes, surgical and procedural activity, working hours, productivity requirements and the overall structure of the practice. Subspecialty is particularly relevant within ophthalmology. The clinical workload associated with retina, glaucoma, corneal disease or another specialist area can differ considerably, meaning the national specialty average cannot capture every individual practice profile. The latest Doximity figure therefore provides ophthalmologists with a useful starting point for evaluating compensation while recognising that individual earnings can differ substantially according to the clinical and contractual characteristics of a particular role. About the data The Doximity 2026 Physician Compensation Report provides compensation benchmarks across a wide range of US medical and surgical specialties. The specialty figures represent average compensation and should be treated as national benchmarks. An individual ophthalmologist’s compensation may differ according to geography, experience, patient volume, surgical and procedural activity, subspecialty, practice setting and other professional factors. Source Doximity. Physician Compensation Report 2026.https://www.doximity.com/reports/physician-compensation-report/2026#modal-close Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Average annual compensation for US hematologists reached $446,700 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in hematology. US hematologists recorded average annual compensation of $446,700, according to Doximity’s 2026 Physician Compensation Report. The latest figure provides hematologists with a specialty-specific benchmark when evaluating their compensation, employment opportunities and the financial expectations associated with their practice. Key findings Doximity reports average annual compensation of $446,700 for hematologists in its 2026 Physician Compensation Report. For hematologists, the figure provides a useful national reference point within a specialty encompassing the diagnosis, treatment and long-term management of malignant and non-malignant blood disorders. The national average should not be interpreted as the compensation every hematologist will receive. Individual earnings can vary according to geography, experience, patient population, disease focus, clinical responsibilities, practice setting and employment structure. Hematologist compensation reaches $446,700 The $446,700 average establishes a current national compensation benchmark for US hematologists. Hematology encompasses a broad range of blood disorders, including anemia, bleeding and clotting disorders, hemoglobinopathies and hematologic malignancies such as leukemia, lymphoma and multiple myeloma. Individual hematologists may concentrate on malignant hematology, non-malignant blood disorders, coagulation medicine or other areas of specialist practice. Some roles also combine hematology with medical oncology. These differences can create substantially different patient populations, treatment responsibilities and workloads between individual hematology practices. For hematologists reviewing their current compensation or considering a new position, the Doximity figure provides a useful specialty-specific reference against which an individual package can be assessed. What influences hematologist compensation? Hematology combines complex diagnostic work with longitudinal patient management, meaning patient volume, disease focus, treatment responsibilities and practice structure can all be important when evaluating individual compensation. Hematologists treating patients with hematologic malignancies may have substantial responsibilities relating to systemic therapies, treatment monitoring, toxicity management and coordination with multidisciplinary cancer services. Those specialising in non-malignant hematology may manage patients with complex bleeding, clotting, red blood cell and other chronic hematologic disorders requiring ongoing specialist assessment. Geography, experience and employment model can further influence compensation. Hematologists may work within hospitals, academic medical centres, comprehensive cancer centres, health systems or specialist practices, with different organisations using different salary, productivity and incentive arrangements. These factors mean the $446,700 national average should be treated as a benchmark rather than an expected salary for every hematologist. What the latest figure means for hematologists For US hematologists, $446,700 provides a contemporary national reference point when benchmarking existing compensation or assessing a prospective position. When reviewing an employment opportunity, hematologists should consider headline compensation alongside expected patient volumes, disease focus, treatment responsibilities, working hours, call commitments and productivity requirements. The precise nature of the hematology role is particularly important. A physician specialising in malignant hematology may have considerably different clinical responsibilities from one focused on non-malignant blood disorders or coagulation medicine. The latest Doximity figure therefore provides hematologists with a useful starting point for evaluating compensation while recognising that individual earnings can differ substantially according to the clinical and contractual characteristics of a particular role. About the data The Doximity 2026 Physician Compensation Report provides compensation benchmarks across a wide range of US medical and surgical specialties. The specialty figures represent average compensation and should be treated as national benchmarks. An individual hematologist’s compensation may differ according to geography, experience, patient population, disease focus, clinical responsibilities, practice setting and other professional factors. Source Doximity. Physician Compensation Report 2026.https://www.doximity.com/reports/physician-compensation-report/2026#modal-close Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Average annual compensation for US pulmonologists reached $441,472 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in pulmonology. US pulmonologists recorded average annual compensation of $441,472, according to Doximity’s 2026 Physician Compensation Report. The latest figure provides pulmonologists with a specialty-specific benchmark when evaluating their compensation, employment opportunities and the financial expectations associated with their practice. Key findings Doximity reports average annual compensation of $441,472 for pulmonologists in its 2026 Physician Compensation Report. For pulmonologists, the figure provides a useful national reference point within a specialty focused on the diagnosis, treatment and long-term management of respiratory disease. The national average should not be interpreted as the compensation every pulmonologist will receive. Individual earnings can vary according to geography, experience, patient volume, disease focus, procedural activity, call responsibilities, practice setting and employment structure. Pulmonologist compensation reaches $441,472 The $441,472 average establishes a current national compensation benchmark for US pulmonologists. Pulmonology encompasses the management of a broad range of respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, pulmonary hypertension, sleep-related breathing disorders and other acute and chronic pulmonary conditions. Clinical practice can combine outpatient consultations and long-term disease management with inpatient respiratory care and diagnostic procedures such as bronchoscopy and pulmonary function assessment. Individual pulmonologists may also develop expertise in areas such as interventional pulmonology, pulmonary hypertension, interstitial lung disease, lung transplantation or sleep medicine, creating considerable variation between individual practices. For pulmonologists reviewing their current compensation or considering a new position, the Doximity figure provides a useful specialty-specific reference against which an individual package can be assessed. What influences pulmonologist compensation? Pulmonology combines longitudinal patient management with diagnostic and procedural activity, meaning patient volume, disease complexity, procedural workload and subspecialty focus can all be important when evaluating individual compensation. A pulmonologist managing complex interstitial lung disease or pulmonary hypertension may have a different clinical workload from a physician whose practice includes a greater proportion of general respiratory medicine or procedural pulmonology. Hospital and call responsibilities can also affect the demands of individual roles, particularly where pulmonologists provide inpatient respiratory consultations or participate in acute respiratory care. Geography, experience and employment model can further influence compensation. Pulmonologists may work within hospitals, health systems, academic medical centres, specialist pulmonary groups or other practice structures, with different organisations using different salary, productivity and incentive arrangements. These factors mean the $441,472 national average should be treated as a benchmark rather than an expected salary for every pulmonologist. What the latest figure means for pulmonologists For US pulmonologists, $441,472 provides a contemporary national reference point when benchmarking existing compensation or assessing a prospective position. When reviewing an employment opportunity, pulmonologists should consider headline compensation alongside expected patient volumes, disease complexity, procedural responsibilities, call commitments, working hours and productivity requirements. The precise clinical focus of the role is particularly important. The workload associated with interventional pulmonology, pulmonary hypertension or advanced lung disease can differ substantially from that of a predominantly outpatient general pulmonology practice. The latest Doximity figure therefore provides pulmonologists with a useful starting point for evaluating compensation while recognising that individual earnings can differ substantially according to the clinical and contractual characteristics of a particular role. About the data The Doximity 2026 Physician Compensation Report provides compensation benchmarks across a wide range of US medical and surgical specialties. The specialty figures represent average compensation and should be treated as national benchmarks. An individual pulmonologist’s compensation may differ according to geography, experience, patient volume, disease focus, procedural activity, call responsibilities, practice setting and other professional factors. Source Doximity. Physician Compensation Report 2026.https://www.doximity.com/reports/physician-compensation-report/2026#modal-close Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Average annual compensation for US pediatric general surgeons reached $627,126 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in the specialty. US pediatric general surgeons recorded average annual compensation of $627,126, according to Doximity’s 2026 Physician Compensation Report. The latest figure provides pediatric surgeons with a specialty-specific benchmark when evaluating their compensation, employment opportunities and the financial expectations associated with their practice. Key findings Doximity reports average annual compensation of $627,126 for Pediatric (General) Surgery in its 2026 Physician Compensation Report. For pediatric surgeons, the figure provides a useful national reference point within a highly specialised surgical field focused on the operative care of infants, children and adolescents. The national average should not be interpreted as the compensation every pediatric surgeon will receive. Individual earnings can vary according to geography, experience, surgical workload, case complexity, call responsibilities, practice setting and employment structure. Pediatric surgeon compensation reaches $627,126 The $627,126 average establishes a current national compensation benchmark for US pediatric general surgeons. Pediatric surgery encompasses the surgical management of a broad range of congenital and acquired conditions affecting children. Depending on their practice, pediatric surgeons may undertake neonatal surgery, gastrointestinal procedures, oncologic surgery, thoracic procedures, trauma care and other complex operations. The breadth and complexity of this work means individual practice profiles and workloads can differ substantially. For pediatric surgeons reviewing an existing compensation package or considering a new position, the Doximity figure provides a national specialty benchmark against which an individual offer can be assessed. What influences pediatric surgeon compensation? Pediatric general surgery combines highly specialised surgical expertise with the management of a comparatively distinct patient population, and individual compensation can be influenced by case mix, surgical volume and complexity. Call responsibilities can also be an important consideration. Pediatric surgeons working in tertiary children's hospitals and trauma centres may provide emergency surgical coverage alongside scheduled operative and outpatient activity. Geography, experience and employment structure can further influence compensation. Pediatric surgeons may work within children's hospitals, academic medical centres, health systems and specialist surgical groups, with different organisations using different salary, productivity and incentive arrangements. Academic, teaching, research and leadership responsibilities may also form part of an individual physician's role. These factors mean the $627,126 national average should be treated as a benchmark rather than an expected salary for every pediatric surgeon. What the latest figure means for pediatric surgeons For US pediatric surgeons, $627,126 provides a contemporary national reference point when benchmarking current compensation or assessing a prospective position. When considering an employment opportunity, pediatric surgeons should evaluate compensation alongside surgical volume, case complexity, call frequency, working hours, academic responsibilities and productivity expectations. The clinical environment is also important. A position within a major tertiary children's hospital may carry substantially different responsibilities from a role within another practice setting, even where both positions fall under pediatric general surgery. The latest Doximity figure therefore provides pediatric surgeons with a useful starting point for evaluating compensation while recognising that individual packages need to be assessed against the specific clinical and contractual responsibilities of the role. About the data The Doximity 2026 Physician Compensation Report provides compensation benchmarks across a wide range of US medical and surgical specialties. The specialty figures represent average compensation and should be treated as national benchmarks. An individual pediatric surgeon’s compensation may differ according to geography, experience, surgical activity, case complexity, call responsibilities, practice setting and other professional factors. Source Doximity. Physician Compensation Report 2026.https://www.doximity.com/reports/physician-compensation-report/2026#modal-close Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Average annual compensation for US interventional radiologists reached $634,658 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in the specialty. US interventional radiologists recorded average annual compensation of $634,658, according to Doximity’s 2026 Physician Compensation Report. The latest figure provides interventional radiologists with a specialty-specific benchmark when evaluating compensation, employment opportunities and the financial expectations associated with their practice. Key findings Doximity reports average annual compensation of $634,658 for interventional radiologists in its 2026 Physician Compensation Report. For interventional radiologists, the figure provides a useful national reference point within a specialty combining diagnostic imaging expertise with minimally invasive image-guided procedures. The national average should not be interpreted as the compensation every interventional radiologist will receive. Individual earnings can vary according to geography, experience, procedural workload, call responsibilities, practice setting and employment structure. Interventional radiologist compensation reaches $634,658 The $634,658 average establishes a current national compensation benchmark for US interventional radiologists. Interventional radiology encompasses a broad range of image-guided procedures used to diagnose and treat disease. Depending on their clinical practice, interventional radiologists may perform vascular interventions, embolisation, biopsies, drainage procedures, ablation and other minimally invasive treatments. This combination of advanced imaging expertise and procedural medicine means individual practice profiles can vary considerably. For interventional radiologists reviewing their current compensation or considering a new position, the Doximity figure provides a useful reference against which an individual package can be assessed. What influences interventional radiologist compensation? Interventional radiology is a highly procedural specialty, meaning procedure volume, complexity and case mix can be important considerations when evaluating compensation. An individual physician's workload may vary according to the balance between interventional procedures and diagnostic radiology, the types of procedures performed and the patient population served. Call responsibilities can also be significant. Interventional radiologists may provide urgent or emergency procedures outside normal working hours, particularly within hospital-based practices and trauma services. Experience, geography and employment model can further influence compensation. Physicians working within hospitals, academic centres, radiology groups or other practice structures may have different base compensation, productivity incentives and contractual arrangements. These factors mean the $634,658 national average should be treated as a benchmark rather than an expected salary for every interventional radiologist. What the latest figure means for interventional radiologists For US interventional radiologists, $634,658 provides a contemporary national reference point when benchmarking existing compensation or assessing a prospective role. When evaluating an employment opportunity, physicians should consider the headline compensation alongside procedural expectations, diagnostic responsibilities, call frequency, working hours and productivity requirements. The precise nature of the practice is particularly relevant in interventional radiology. Two positions carrying the same specialty title may involve substantially different procedure volumes, case complexity, diagnostic workloads and on-call commitments. The latest Doximity figure therefore provides interventional radiologists with a useful starting point for assessing compensation while recognising that individual packages need to be evaluated against the responsibilities and structure of the specific role. About the data The Doximity 2026 Physician Compensation Report provides compensation benchmarks across a wide range of US medical and surgical specialties. The specialty figures represent average compensation and should be treated as national benchmarks. An individual interventional radiologist’s compensation may differ according to geography, experience, procedural activity, call responsibilities, practice setting and other professional factors. Source Doximity. Physician Compensation Report 2026.https://www.doximity.com/reports/physician-compensation-report/2026#modal-close Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Average annual compensation for US orthopaedic surgeons reached $696,852 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in the specialty. US orthopaedic surgeons recorded average annual compensation of $696,852, according to Doximity’s 2026 Physician Compensation Report. The latest figure provides orthopaedic surgeons with a current specialty-specific benchmark when evaluating their compensation, employment arrangements and earning potential. Key findings Doximity reports average annual compensation of $696,852 for orthopaedic surgeons in its 2026 Physician Compensation Report. For orthopaedic surgeons, the figure provides a useful national reference point when assessing compensation within a specialty encompassing surgical and procedural treatment across a broad range of musculoskeletal conditions. The national average should not be interpreted as the compensation every orthopaedic surgeon should expect. Individual earnings can vary according to geography, experience, subspecialty, surgical workload, call responsibilities, practice setting and compensation structure. Orthopaedic surgeon compensation reaches $696,852 The $696,852 average establishes a new national compensation benchmark for US orthopaedic surgeons. Orthopaedic practice can encompass a wide range of clinical areas, including joint replacement, sports medicine, trauma, spine, hand and upper-extremity surgery, foot and ankle surgery and other musculoskeletal procedures. The composition of an individual surgeon’s practice can therefore have an important bearing on workload and compensation. For orthopaedic surgeons reviewing an existing employment agreement or considering a new opportunity, the Doximity figure provides a useful reference against which an individual compensation package can be assessed. However, headline compensation should always be considered alongside the clinical and contractual requirements attached to the role. What influences orthopaedic surgeon compensation? Orthopaedic surgery is a procedure-intensive specialty, and individual compensation can be influenced by surgical volume, case mix and subspecialty focus. An orthopaedic surgeon specialising in joint replacement may have a substantially different practice profile from a colleague working predominantly in trauma, sports medicine or hand surgery. Experience, productivity arrangements, geographic market and call commitments can also affect compensation. Practice setting is another important consideration. Compensation structures can differ between hospital-employed physicians, academic medical centres, single-specialty groups and other practice models. Productivity incentives, leadership responsibilities and contractual arrangements may further influence total annual compensation, meaning the national average is best used as a benchmark rather than an expected salary for every orthopaedic surgeon. What the latest figure means for orthopaedic surgeons For US orthopaedic surgeons, $696,852 provides a contemporary national reference point when benchmarking current compensation or evaluating a prospective role. When reviewing an offer, surgeons should consider how their compensation compares with the Doximity benchmark while also examining surgical volume expectations, call commitments, productivity targets, working hours and the overall structure of the package. Subspecialty and location can also be important. An individual orthopaedic surgeon’s market value may differ considerably from the national average depending on their expertise and the demand for their services within a particular geographic market. The latest Doximity figure therefore gives orthopaedic surgeons a useful starting point for assessing compensation while recognising that $696,852 represents an average across the specialty rather than an expected figure for every individual physician. About the data The Doximity 2026 Physician Compensation Report provides compensation benchmarks across a wide range of US medical and surgical specialties. The specialty figures represent average compensation and should be treated as national benchmarks. An individual orthopaedic surgeon’s compensation may differ according to geography, experience, working arrangements, subspecialty, practice setting and other professional factors. Source Doximity. Physician Compensation Report 2026.https://www.doximity.com/reports/physician-compensation-report/2026#modal-close Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Average annual compensation for US thoracic surgeons reached $749,707 in Doximity’s 2026 Physician Compensation Report, providing a new national benchmark for physicians working in the specialty. US thoracic surgeons recorded average annual compensation of $749,707, according to Doximity’s 2026 Physician Compensation Report. The latest figure provides thoracic surgeons with an updated specialty-specific benchmark when evaluating their own compensation, employment arrangements and earning potential. Key findings Doximity reports average annual compensation of $749,707 for thoracic surgeons in its 2026 Physician Compensation Report. For physicians working in thoracic surgery, the figure provides a useful national reference point for assessing compensation within a specialty characterised by complex surgical care and significant procedural responsibilities. The national average should not, however, be interpreted as the amount every thoracic surgeon will earn. Individual compensation can vary considerably depending on factors such as geography, experience, workload, subspecialty focus, call responsibilities, practice setting and employment structure. Thoracic surgeon compensation reaches $749,707 The $749,707 average establishes an updated compensation benchmark for US thoracic surgeons. Thoracic surgery encompasses the surgical management of diseases affecting organs within the chest, with physicians potentially treating conditions involving the lungs, oesophagus, mediastinum and other thoracic structures. Individual practices can therefore differ substantially according to clinical focus and case mix. For thoracic surgeons reviewing their current remuneration or considering a new position, the Doximity figure offers a national specialty benchmark against which an individual compensation package can be considered. It remains important to assess the figure alongside the specific requirements of a role rather than viewing the national average as an expected salary. What influences thoracic surgeon compensation? Thoracic surgery involves highly specialised operative care, with compensation potentially influenced by the complexity and volume of surgical procedures undertaken. Individual thoracic surgeon compensation may also reflect experience, procedural workload, subspecialisation, call commitments, geographic market and employment model. A physician working within a large hospital system may have a different compensation structure from one employed by a specialist surgical group or another practice model. Productivity incentives, leadership responsibilities and other contractual components can further affect total compensation. These factors mean two thoracic surgeons can have significantly different compensation packages even when practising within the same specialty. What the latest figure means for thoracic surgeons For US thoracic surgeons, $749,707 provides a contemporary national reference point when reviewing existing compensation or assessing a prospective position. The figure can be particularly useful during contract discussions, but it should be considered alongside the complete requirements of the role. Surgical volume, call schedules, working hours, clinical responsibilities, location and incentive arrangements can all affect whether an individual compensation package is competitive. Non-financial considerations also matter. Factors such as clinical autonomy, operating capacity, support teams, workload and work-life balance can materially affect the attractiveness of a position even where headline compensation is similar. The latest Doximity data therefore provide thoracic surgeons with a valuable starting point for benchmarking compensation, rather than a single figure that should determine the value of an individual role. About the data The Doximity 2026 Physician Compensation Report provides compensation benchmarks across a wide range of US medical and surgical specialties. The specialty figures represent average compensation and should be treated as national benchmarks. An individual thoracic surgeon’s compensation may differ according to geography, experience, working arrangements, practice setting and other professional factors. Source Doximity. Physician Compensation Report 2026.https://www.doximity.com/reports/physician-compensation-report/2026#modal-close Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Average neurosurgeon compensation increased to $829,161 in Doximity’s 2026 Physician Compensation Report, representing annual growth of 10.7%. Average annual compensation for US neurosurgeons reached $829,161, according to Doximity’s 2026 Physician Compensation Report. Neurosurgery compensation increased by 10.7%, making the latest data particularly relevant for neurosurgeons benchmarking their earnings against the wider US specialty workforce. Key findings Doximity reports average annual compensation of $829,161 for neurosurgeons in its latest analysis. This represents a substantial increase from the $749,140 average compensation reported for neurosurgery in Doximity’s 2025 report. The year-on-year movement equates to an increase of approximately $80,021, with Doximity reporting compensation growth of 10.7% for neurosurgery. For neurosurgeons assessing their own compensation, the figures provide a current national benchmark against which individual employment packages and practice earnings can be considered. Neurosurgeon compensation increases 10.7% The increase from $749,140 to $829,161 represents a significant movement in average compensation for the specialty. Importantly, this is not simply part of an equivalent increase across the entire physician workforce. Doximity reports that overall US physician compensation increased by 2% from 2024 to 2025, compared with the 10.7% increase recorded for neurosurgery. The latest figure therefore provides neurosurgeons with an important new reference point when evaluating compensation. However, the national average should not be interpreted as the salary that every neurosurgeon should expect to receive. Individual compensation can differ substantially according to factors including geography, experience, employment arrangement, workload and practice characteristics. What influences neurosurgeon compensation? Neurosurgery is a highly specialised surgical field involving the diagnosis and operative management of complex conditions affecting the brain, spine and nervous system. A neurosurgeon’s individual compensation can therefore reflect a range of factors, including surgical workload, case mix, subspecialty focus, call responsibilities, experience and employment structure. Practice setting can also be important when interpreting compensation data. Across physicians generally, Doximity found substantial differences in average compensation according to employment setting, with single-specialty groups, multi-specialty groups and hospitals among the settings associated with higher average physician compensation in its 2026 analysis. These broader findings provide context, but the $829,161 figure remains a national neurosurgery average rather than a guaranteed compensation level for a particular role or practice. What the latest figure means for neurosurgeons For US neurosurgeons, the new Doximity figure provides a useful contemporary benchmark when assessing compensation packages, considering a new position or evaluating how individual earnings compare with the national specialty average. The 10.7% annual increase is particularly notable. A neurosurgeon whose compensation has remained relatively static may therefore want to consider the latest market data alongside factors such as location, experience, workload, call commitments and employment model when evaluating their current position. At the same time, compensation should not be considered in isolation. Doximity’s wider 2026 research found that 76% of physicians surveyed were willing to accept lower pay in return for greater autonomy or work-life balance, illustrating the importance physicians place on factors beyond headline earnings. For neurosurgeons, the latest data ultimately establish a new specialty-specific benchmark: average annual compensation of $829,161, following growth of 10.7%. About the data Doximity’s 2026 Physician Compensation Report draws on nearly 23,000 compensation surveys completed by full-time US physicians during 2025, with its broader dataset incorporating more than 250,000 completed compensation surveys over seven years. Doximity states that respondents were full-time US physicians practising at least 40 hours per week. Individual compensation can vary according to geography, experience, working hours, practice setting and other factors, meaning the reported average should be treated as a national specialty benchmark rather than an expected salary for every neurosurgeon. Source Doximity. Physician Compensation Report 2026.https://www.doximity.com/reports/physician-compensation-report/2026#modal-close Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

The agreement gives Cipla exclusive US commercialisation rights to Qilu Pharmaceutical's pembrolizumab biosimilar candidate QL2107, referencing Keytruda. Cipla subsidiary Invagen Pharmaceuticals has entered into an exclusive licensing and supply partnership with Qilu, which will remain responsible for development, regulatory registration and product supply. Cipla USA will commercialise the biosimilar in the United States, positioning the company to participate in the future US market for biosimilar versions of Merck's blockbuster cancer immunotherapy Keytruda. Field Content Alert Type Deal Companies Cipla; Invagen Pharmaceuticals; Qilu Pharmaceutical Deal Type Exclusive licensing and supply partnership Asset or Company QL2107 Therapy Area(s) Oncology Technology or Modality Pembrolizumab biosimilar; PD-1 monoclonal antibody Deal Value Financial terms were not disclosed Geography United States What Happened Cipla subsidiary Invagen Pharmaceuticals entered into an exclusive partnership with Qilu Pharmaceutical for the licensing and supply of QL2107, a biosimilar referencing Keytruda, in the United States. Why It Matters The partnership gives Cipla access to a potential US biosimilar of one of the world's leading oncology medicines and expands its biologics commercialisation portfolio. Supporting Context Qilu will remain responsible for development, regulatory registration and supply, while Cipla USA will handle commercialisation in the US. Strategic Rationale The deal combines Qilu's biosimilar development capabilities with Cipla's established US commercial infrastructure. Potential Impact A successfully approved pembrolizumab biosimilar could increase competition and broaden access to PD-1 immunotherapy in the US oncology market. Key Takeaway Cipla has secured exclusive US commercialisation rights to Qilu's Keytruda biosimilar candidate QL2107. What to Watch US regulatory development of QL2107 and the timing of potential entry into the pembrolizumab biosimilar market. Primary Source Cipla Relevant Date 3 September 2026 Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

The acquisition combines Cureety's therapy-specific oncology monitoring platform with Reimagine Care's AI-enabled virtual cancer-care capabilities. Cureety has acquired US-based Reimagine Care, creating a transatlantic precision-oncology platform supporting more than 250 cancer centres and approximately 100,000 patients across five countries. The combined organisation brings together clinical monitoring and triage technology with AI-supported patient engagement and virtual oncology care, expanding the companies' ability to support patients between hospital visits. Field Content Alert Type Deal Companies Cureety; Reimagine Care Deal Type Acquisition Asset or Company Reimagine Care Therapy Area(s) Oncology Technology or Modality Digital health; AI-enabled virtual oncology care; remote patient monitoring Deal Value Financial terms were not disclosed Geography United States and Europe What Happened Cureety acquired Reimagine Care, combining two digital oncology businesses focused on remote monitoring, patient engagement and virtual cancer care. Why It Matters The transaction creates a larger precision-oncology platform supporting more than 250 cancer centres and around 100,000 patients across five countries. Supporting Context Cureety provides therapy-specific monitoring and clinical triage technology, while Reimagine Care provides AI-supported patient engagement and virtual oncology services. Strategic Rationale The acquisition combines complementary technology and care-delivery capabilities to support more continuous cancer care outside traditional clinical settings. Potential Impact The enlarged platform could help oncology providers monitor more patients remotely, identify deterioration earlier and reduce administrative burden on care teams. Key Takeaway Cureety's acquisition of Reimagine Care creates a scaled transatlantic digital oncology organisation serving more than 100,000 patients. What to Watch Integration of Reimagine Care's AI and virtual-care capabilities into Cureety's platform and expansion across additional oncology providers. Primary Source Cureety Relevant Date 2 September 2026 Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com